SCHEMBL7060058

SCHEMBL7060058

CC(C)(C)[Si](C)(C)Oc1ccc2c(c1)CC[C@@H]1[C@@H]2CC[C@]2(C)C(=CCBr)CC[C@@H]12

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
STS P08842 6/20 0.50
LMNA P02545 3/20 0.50
MAPT P10636 3/20 0.50
HSD17B1 P14061 3/20 0.50
RECQL P46063 1/20 0.50
SMN1; SMN2 Q16637 1/20 0.50
ESR1 P03372 3/20 0.47
KDM4E B2RXH2 2/20 0.47
ALDH1A1 P00352 2/20 0.47
CYP2C9 P11712 2/20 0.47
ESR2 Q92731 2/20 0.47
ABCC1 P33527 2/20 0.47
ABCC4 O15439 1/20 0.47
SLCO1B1 Q9Y6L6 1/20 0.47
CA1 P00915 1/20 0.47
CA2 P00918 1/20 0.47
CA4 P22748 1/20 0.47
CA6 P23280 1/20 0.47
CA9 Q16790 1/20 0.47
HSD17B10 Q99714 3/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1656763 1.00 STS (0.50) STSLMNAMAPTHSD17B1RECQL
SCHEMBL8409267 0.94 STS (0.51) STSLMNAMAPTHSD17B1RECQL
SCHEMBL12888961 0.92 STS (0.49) STSLMNAMAPTHSD17B1RECQL
SCHEMBL1236171 0.92 STS (0.49) STSLMNAMAPTHSD17B1RECQL
SCHEMBL1236173 0.92 STS (0.49) STSLMNAMAPTHSD17B1RECQL
SCHEMBL1659350 0.92 STS (0.49) STSLMNAMAPTHSD17B1RECQL
SCHEMBL1237598 0.86 STS (0.49) STSLMNAMAPTHSD17B1RECQL
SCHEMBL1237597 0.86 STS (0.49) STSLMNAMAPTHSD17B1RECQL
SCHEMBL1657651 0.85 KDM4E (0.52) STSLMNAMAPTHSD17B1RECQL
SCHEMBL8410997 0.84 KDM4E (0.49) STSLMNAMAPTHSD17B1RECQL

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1310509-A2 Novel anti-estrogenic steroids, and associated pharmaceutical compositions and methods of use Sri International (US) 2003-05-14 EP disclosed